Publications by authors named "Mattias F Duytschaever"
Article Synopsis
- This study evaluated a new catheter designed for high-power, short-duration ablation to treat paroxysmal atrial fibrillation, focusing on its safety and effectiveness in the short term.
- The clinical trial, named QDOT-FAST, included 52 patients and showed that the catheter successfully isolated pulmonary veins in all cases with very few adverse events.
- Most patients (94.2%) maintained sinus rhythm after 3 months, with only two reported adverse incidents, confirming the procedure is generally safe and effective.
Background: There are anecdotal reports of sudden death despite a functional implantable cardioverter defibrillator (ICD). We sought to describe scenarios leading to fatal or near-fatal outcome due to inappropriately inhibited ICD therapy in devices programmed with single-chamber detection criteria.
Methods: Programmed settings, episode lists, and intracardiac electrograms from 24 patients with a life-threatening event (n = 12) or fatal outcome (n = 12) related to failed ventricular arrhythmia detection were used to clarify the underlying scenario.